French pharmaceutical giant Sanofi is set to collaborate with OpenAI, the U.S. developer of artificial intelligence chatbot ChatGPT, to build AI-powered software to accelerate drug development.
Trending
- Nasarawa reviews public health bills to boost health security
- NPC begins child survival data mapping in Gombe
- Abia govt approves health insurance scheme for civil servants
- UBEC: State govts fail to access ₦136bn matching grants
- G20 leaders inaugurate global alliance to end hunger
- CISLAC applauds Supreme Court for upholding EFCC’s authority
- YouthWASH urges prioritisation of toilets, sanitation
- Lassa fever: Physician emphasises improved household, community hygiene
